C.J. George Chang

Statistics

Publications

Citations

150

H-Index

Active since

2018

Affiliations

Center for Drug Evaluation and Research(Current)

C.J. George Chang is an author at Center for Drug Evaluation and Research specializing in metastatic breast cancer treatment, metastatic breast cancer, and breast cancer pharmacotherapy.

ORCID

Publications per year

2018–2021

Publications

FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Anand Shah, Erik Bloomquist, Shenghui Tang et al. · Clinical Cancer Research · 2018 · 111 citations

Medicine, Oncology, Pharmacology +15

FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer

Melanie Royce, Christy Osgood, Anup Amatya et al. · Clinical Cancer Research · 2021 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2